Prognostic and Clinical Value of Interleukin 6 and CD45⁺CD14⁺ Inflammatory Cells with PD-L1⁺/PD-L2⁺ Expression in Patients with Different Manifestation of Ovarian Cancer

Table 3

Levels of IL-6 (pg/ml) in the plasma and PF of patients with different FIGO stages, grades, and Kurman-Shih types of ovarian cancer.

Concentration of IL-6 (pg/ml) in ovarian cancer patients ()		Plasma			Peritoneal fluid
		Median	Minimum	Maximum	Median	Minimum	Maximum
FIGO stage	I-II ()	14.82	2.98	89.17	2745.37	29.01	11947.10
	III-IV ()	22.18	3.45	162.15	5254.85	115.27	24310.80
Grade	G2 ()	27.69	3.45	107.92	3135.68	464.75	19882.90
	G3 ()	17.87	2.98	162.15	4816.36	29.01	24310.80
Kurman and Shih type	I ()	21.72	2.98	162.15	3853.14	29.01	24037.60
	II ()	18.60	6.69	121.69	4701.35	115.27	24310.80

in relation to patients with grade 2 (G2) of ovarian cancer.